Page last updated: 2024-08-25

3,4-dihydroxyphenylethanol and Inflammatory Bowel Diseases

3,4-dihydroxyphenylethanol has been researched along with Inflammatory Bowel Diseases in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	1 (100.00)	2.80

Authors

Authors	Studies
Miao, F	1

Other Studies

1 other study(ies) available for 3,4-dihydroxyphenylethanol and Inflammatory Bowel Diseases

Article	Year
Hydroxytyrosol alleviates dextran sodium sulfate-induced colitis by inhibiting NLRP3 inflammasome activation and modulating gut microbiota in vivo. Nutrition (Burbank, Los Angeles County, Calif.), 2022, Volume: 97 Topics: Animals; Antioxidants; Colitis; Colitis, Ulcerative; Colon; Dextran Sulfate; Disease Models, Animal; Gastrointestinal Microbiome; Inflammasomes; Inflammatory Bowel Diseases; Mice; Mice, Inbred C57BL; NLR Family, Pyrin Domain-Containing 3 Protein; Phenylethyl Alcohol; Sulfates	2022

Article

Year

Hydroxytyrosol alleviates dextran sodium sulfate-induced colitis by inhibiting NLRP3 inflammasome activation and modulating gut microbiota in vivo.

Nutrition (Burbank, Los Angeles County, Calif.), 2022, Volume: 97

Topics: Animals; Antioxidants; Colitis; Colitis, Ulcerative; Colon; Dextran Sulfate; Disease Models, Animal; Gastrointestinal Microbiome; Inflammasomes; Inflammatory Bowel Diseases; Mice; Mice, Inbred C57BL; NLR Family, Pyrin Domain-Containing 3 Protein; Phenylethyl Alcohol; Sulfates

2022